Homepage > Company > Media > Pharma News > 2018 > Merck KGaA partners with Alibaba Health in China

Merck KGaA partners with Alibaba Health in China

Merck KGaA (MRK.XE) said Wednesday that it signed a collaboration agreement with Alibaba Health Information Technology Ltd. (0241.HK) to provide healthcare services in China.

The partnership will focus on drug the track and trace of drugs and internet health services, but may eventually venture into pharmaceutical e-commerce and artificial intelligence, Merck said.

Published: June 20, 2018

https://www.marketwatch.com/

Read also

EC approves AstraZeneca’s Fasenra for EGPA treatment

The European Commission (EC) has approved AstraZeneca‘s Fasenra (benralizumab) as an add-on therapy for adults with relapsing or refractory eosinophilic granulomatosis with polyangii...

Genprex reports positive preclinical gene therapy data

Genprex, Inc., a clinical-stage gene therapy company, announced positive preclinical results for its lead drug candidate, Reqorsa® (quratusugene ozeplasmid) Gene Therapy, at the recent EORTC-...

Astellas withdraws Europe ACP application for AMD treatment

Astellas Pharma has announced the withdrawal of its marketing authorisation application for IZERVAY (avacincaptad pegol, ACP) intravitreal solution to treat geographic atrophy (GA) sec...

New report demands greater understanding of the impact of change on academia

Digital Science, a technology company serving stakeholders across the research ecosystem, is today calling for greater awareness of the impact that a myriad of fast-developing technologies are having ...